Bioxytran, Inc.
BIXT
$0.02
$0.005.42%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 70.04% | -296.21% | -84.72% | -898.59% | 102.62% |
| Total Depreciation and Amortization | 166.67% | -27.59% | -30.95% | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -105.49% | 1,264.41% | 237.80% | 72.68% | -126.29% |
| Change in Net Operating Assets | -22.67% | 144.16% | -41.92% | 92.57% | 2.87% |
| Cash from Operations | -46.61% | -0.68% | -471.08% | 43.31% | 56.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.17% | -48.39% | -264.71% | 86.61% | -- |
| Cash from Investing | -2.17% | -48.39% | -264.71% | 86.61% | -- |
| Total Debt Issued | -- | -- | -49.51% | -56.45% | -43.18% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -68.91% | -65.77% | 3,076.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -70.51% | -67.39% | -- | -- | -- |
| Cash from Financing | -63.43% | -72.79% | 1,255.23% | -35.58% | -49.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -509.17% | -109.47% | 4,245.61% | 1,050.00% | -50.00% |